NCT07293273Completed
Procedural Sedation in Renal Sympathetic Denervation
Impact of Dexmedetomidine and Fentanyl-Propofol Sedation on Peri- and Postprocedural Outcomes in Renal Sympathetic Denervation: A Single-Center Retrospective Study
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
This retrospective, single-center study investigates the effects of two different sedation regimens-dexmedetomidine versus fentanyl-propofol-on clinical outcomes in patients undergoing catheter-based renal sympathetic denervation for resistant hypertension. The study focuses on peri-procedural safety, recovery, and overall tolerability of sedation approaches in this interventional setting.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 142 (actual)
- First submitted
- 7 Dec 2025
- Start date
- 30 Dec 2024
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Ebru Girgin Dinc
- Diseases
- High blood pressure
- NCT number
- NCT07293273
What you commit to
- Study type: Observational
- Participants enrolled: 142
- From 30 Dec 2024 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18
Other
- Pregnant women
Who the study is looking for
- Age 18-80 years
- Underwent renal sympathetic denervation for resistant essential hypertension (2023-2024)
- Both male and female
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kosuyolu Heart Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.